All-trans retinoic acid as an alternative to chemotherapy in the treatment of acute promyelocytic leukemia

Pediatr Hematol Oncol. 1993 Oct-Dec;10(4):363-7. doi: 10.3109/08880019309029517.

Abstract

A 12-year-old girl with acute promyelocytic leukemia has been treated with conventional chemotherapy. The patient remained in complete remission for a year when the first bone marrow relapse occurred. Since reinduction chemotherapy was rejected by the parents, an alternative treatment with oral all-trans retinoic acid was administered. A second complete remission was achieved within 100 days. After 14 months a second bone marrow relapse occurred. All-trans retinoic acid and the combination with interferon-alpha failed.

Publication types

  • Case Reports

MeSH terms

  • Child
  • Female
  • Humans
  • Leukemia, Promyelocytic, Acute / drug therapy*
  • Receptors, Retinoic Acid / genetics
  • Tretinoin / therapeutic use*

Substances

  • Receptors, Retinoic Acid
  • Tretinoin